Codexis applies cutting-edge protein engineering science to custom-design enzymes and biocatalysts that optimize industrial manufacturing processes. By harnessing its proprietary technology platform, the company assists pharmaceutical and life science partners in replacing traditional, harsh chemical synthesis methods with clean, highly efficient biological alternatives. Its core operations target small-molecule pharmaceutical biocatalysis and advanced nucleic acid manufacturing, driving innovation in drug development, green chemistry, and sustainable industrial production methods worldwide.